682 related articles for article (PubMed ID: 31230959)
41. Significance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer.
Tewari M
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):572-578. PubMed ID: 27919845
[TBL] [Abstract][Full Text] [Related]
42. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G;
Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050
[TBL] [Abstract][Full Text] [Related]
43. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
[TBL] [Abstract][Full Text] [Related]
44. The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study.
Hackert T; Strobel O; Michalski CW; Mihaljevic AL; Mehrabi A; Müller-Stich B; Berchtold C; Ulrich A; Büchler MW
HPB (Oxford); 2017 Nov; 19(11):1001-1007. PubMed ID: 28838632
[TBL] [Abstract][Full Text] [Related]
45. Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma.
Sgroi MD; Narayan RR; Lane JS; Demirjian A; Kabutey NK; Fujitani RM; Imagawa DK
J Vasc Surg; 2015 Feb; 61(2):475-80. PubMed ID: 25441672
[TBL] [Abstract][Full Text] [Related]
46. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
47. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
48. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
[TBL] [Abstract][Full Text] [Related]
49. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?
Turrini O; Ewald J; Barbier L; Mokart D; Blache JL; Delpero JR
Ann Surg; 2013 Apr; 257(4):726-30. PubMed ID: 22968078
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
51. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
[TBL] [Abstract][Full Text] [Related]
52. Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?
Marchegiani G; Andrianello S; Perri G; Secchettin E; Maggino L; Malleo G; Bassi C; Salvia R
HPB (Oxford); 2018 May; 20(5):411-417. PubMed ID: 29191689
[TBL] [Abstract][Full Text] [Related]
53. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
54. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.
Fujii T; Nakao A; Yamada S; Suenaga M; Hattori M; Takami H; Inokawa Y; Kanda M; Sugimoto H; Nomoto S; Murotani K; Kodera Y
Surgery; 2015 Apr; 157(4):708-15. PubMed ID: 25704426
[TBL] [Abstract][Full Text] [Related]
55. Venous thrombosis following pancreaticoduodenectomy with venous resection.
Mohammed S; Mendez-Reyes JE; McElhany A; Gonzales-Luna D; Van Buren G; Bland DS; Villafane-Ferriol N; Pierzynski JA; West CA; Silberfein EJ; Fisher WE
J Surg Res; 2018 Aug; 228():271-280. PubMed ID: 29907222
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion].
Kriger AG; Karmazanovsky GG; Smirnov AV; Kharazov AF; Gorin DS; Raevskaya MB; Galkin GV; Revishvili AS
Khirurgiia (Mosk); 2018; (12):21-29. PubMed ID: 30560841
[TBL] [Abstract][Full Text] [Related]
57. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
[TBL] [Abstract][Full Text] [Related]
58. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
[TBL] [Abstract][Full Text] [Related]
59. Significance of Simultaneous Splenic Artery Resection in Left-Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein Resection.
Gyoten K; Mizuno S; Nagata M; Ogura T; Usui M; Isaji S
World J Surg; 2017 Aug; 41(8):2111-2120. PubMed ID: 28258459
[TBL] [Abstract][Full Text] [Related]
60. The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy.
Kantor O; Talamonti MS; Wang CH; Roggin KK; Bentrem DJ; Winchester DJ; Prinz RA; Baker MS
HPB (Oxford); 2018 Feb; 20(2):140-146. PubMed ID: 29191690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
